What are Niagen Bioscience, Inc. Common Stock's profit margins?

Niagen Bioscience, Inc. Common Stock (NAGE) runs a 64.3% gross margin and a 10.0% operating margin, with a 14.3% net margin.

Where do Niagen Bioscience, Inc. Common Stock's ratios come from?

Every ratio is computed from Niagen Bioscience, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Niagen Bioscience, Inc. Common Stock NAGE Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	64.3%+2.4pp	61.8%+1.1pp	60.8%—	——
Operating margin	12.6%+4.8pp	7.8%+14.5pp	-6.7%—	——
Net margin	13.4%+4.8pp	8.6%+14.6pp	-6%—	——
EBITDA margin	13.2%+4.6pp	8.6%+14.0pp	-5.5%—	——
Returns
Return on equity	28.3%+5.4pp	22.9%+40.6pp	-17.7%—	——
Return on assets	19.9%+6.0pp	13.9%+23.1pp	-9.3%—	——
Return on invested capital	167.3%-101pp	268.6%+349pp	-80.1%—	——
Efficiency
Asset turnover	1.5×-0.1×	1.6×+0.1×	1.5×—	——
Inventory turnover	3.1×-0.1×	3.2×+1.0×	2.2×—	——
Liquidity
Current ratio	4.9×+1.3×	3.6×+1.2×	2.4×-0.2×	2.6×-0.2×
Quick ratio	3.8×+0.8×	3.1×+1.4×	1.7×-0.1×	1.8×-0.2×
Cash ratio	3.3×+0.8×	2.5×+1.2×	1.3×+0.2×	1.1×-0.5×
Leverage
Debt-to-equity	0×0.0×	0.1×0.0×	0×-0.1×	0.1×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×-0.1×	0.1×0.0×
Net debt / EBITDA	-3.6×+1.3×	-4.9×—	——	——
Interest coverage	8.5×+1.7×	6.8×+15.3×	-8.5×—	——
Per Share
Book value per share	$0.90+51.8%	$0.59+55.5%	$0.38-7.7%	$0.41-12.9%
Valuation
Market capitalization	$254.07M-74.9%	——	——	——
Enterprise value	$190.09M-79.7%	——	——	——
Price / earnings	13.6×-43.5×	——	——	——
Price / sales	2×-6.8×	——	——	——
Price / book	3.3×-13.6×	——	——	——
EV / EBITDA	15×-44.1×	——	——	——
EV / sales	1.6×-7.3×	——	——	——
Earnings yield	6.8%+5.2pp	——	——	——
PEG ratio	0.5×—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Niagen Bioscience, Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Niagen Bioscience, Inc. Common Stock's profit margins?: Niagen Bioscience, Inc. Common Stock (NAGE) runs a 64.3% gross margin and a 10.0% operating margin, with a 14.3% net margin.
Where do Niagen Bioscience, Inc. Common Stock's ratios come from?: Every ratio is computed from Niagen Bioscience, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.